These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 19846809

  • 1. Aberrant underexpression of CD81 in precursor B-cell acute lymphoblastic leukemia: utility in detection of minimal residual disease by flow cytometry.
    Muzzafar T, Medeiros LJ, Wang SA, Brahmandam A, Thomas DA, Jorgensen JL.
    Am J Clin Pathol; 2009 Nov; 132(5):692-8. PubMed ID: 19846809
    [Abstract] [Full Text] [Related]

  • 2. Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia.
    Veltroni M, De Zen L, Sanzari MC, Maglia O, Dworzak MN, Ratei R, Biondi A, Basso G, Gaipa G, I-BFM-ALL-FCM-MRD-Study Group.
    Haematologica; 2003 Nov; 88(11):1245-52. PubMed ID: 14607753
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
    DiGiuseppe JA, Fuller SG, Borowitz MJ.
    Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
    [Abstract] [Full Text] [Related]

  • 4. Multiparametric flow cytometry in detection of minimal residual disease in acute lymphoblastic leukemia of early B-cell phenotype.
    Mlcáková A, Babusíková O.
    Neoplasma; 2003 Mar; 50(6):416-21. PubMed ID: 14689062
    [Abstract] [Full Text] [Related]

  • 5. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
    Liu YR, Wang H, Chang Y, Cheng YF, Fu JY, Zhang LP, Liu GL, Chen SS.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473
    [Abstract] [Full Text] [Related]

  • 6. [Application of triple-color flow cytometry for minimal residual disease detection in acute B-lymphoblastic leukemia].
    Chen T, Zhu Y, Zhou X, Wang Y, Ying D.
    Zhonghua Xue Ye Xue Za Zhi; 2001 Jan; 22(1):20-3. PubMed ID: 11877045
    [Abstract] [Full Text] [Related]

  • 7. Modulation of antigen expression in B-cell precursor acute lymphoblastic leukemia during induction therapy is partly transient: evidence for a drug-induced regulatory phenomenon. Results of the AIEOP-BFM-ALL-FLOW-MRD-Study Group.
    Dworzak MN, Gaipa G, Schumich A, Maglia O, Ratei R, Veltroni M, Husak Z, Basso G, Karawajew L, Gadner H, Biondi A.
    Cytometry B Clin Cytom; 2010 May; 78(3):147-53. PubMed ID: 20201055
    [Abstract] [Full Text] [Related]

  • 8. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
    Cáp J, Babusíková O, Kaiserová E, Jamárik M.
    Neoplasma; 1998 May; 45(4):231-6. PubMed ID: 9890666
    [Abstract] [Full Text] [Related]

  • 9. Distinct expression patterns of CD123 and CD34 on normal bone marrow B-cell precursors ("hematogones") and B lymphoblastic leukemia blasts.
    Hassanein NM, Alcancia F, Perkinson KR, Buckley PJ, Lagoo AS.
    Am J Clin Pathol; 2009 Oct; 132(4):573-80. PubMed ID: 19762535
    [Abstract] [Full Text] [Related]

  • 10. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
    Babusíková O, Glasová M, Koníková E, Kusenda J.
    Neoplasma; 1996 Oct; 43(6):367-72. PubMed ID: 8996560
    [Abstract] [Full Text] [Related]

  • 11. Flow cytometric determination of leukemia-associated marker combinations for the study of minimal residual disease.
    Babusíková O, Glasová M, Kusenda J, Koníková E, Mésárosová A.
    Neoplasma; 1994 Oct; 41(6):305-13. PubMed ID: 7870213
    [Abstract] [Full Text] [Related]

  • 12. Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real-time PCR.
    Kerst G, Kreyenberg H, Roth C, Well C, Dietz K, Coustan-Smith E, Campana D, Koscielniak E, Niemeyer C, Schlegel PG, Müller I, Niethammer D, Bader P.
    Br J Haematol; 2005 Mar; 128(6):774-82. PubMed ID: 15755280
    [Abstract] [Full Text] [Related]

  • 13. Unique pattern of nuclear TdT immunofluorescence distinguishes normal precursor B cells (Hematogones) from lymphoblasts of precursor B-lymphoblastic leukemia.
    Hurford MT, Altman AJ, DiGiuseppe JA, Sherburne BJ, Rezuke WN.
    Am J Clin Pathol; 2008 May; 129(5):700-5. PubMed ID: 18426728
    [Abstract] [Full Text] [Related]

  • 14. Role of CD81 and CD58 in minimal residual disease detection in pediatric B lymphoblastic leukemia.
    Tsitsikov E, Harris MH, Silverman LB, Sallan SE, Weinberg OK.
    Int J Lab Hematol; 2018 Jun; 40(3):343-351. PubMed ID: 29500862
    [Abstract] [Full Text] [Related]

  • 15. NRP-1/CD304 expression in acute leukemia: a potential marker for minimal residual disease detection in precursor B-cell acute lymphoblastic leukemia.
    Meyerson HJ, Blidaru G, Edinger A, Osei E, Schweitzer K, Fu P, Ho L.
    Am J Clin Pathol; 2012 Jan; 137(1):39-50. PubMed ID: 22180477
    [Abstract] [Full Text] [Related]

  • 16. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
    Zeleznikova T, Stevulova L, Kovarikova A, Babusikova O.
    Neoplasma; 2007 Jan; 54(6):471-7. PubMed ID: 17949229
    [Abstract] [Full Text] [Related]

  • 17. The knowledge on the 3rd type hematogones could contribute to more precise detection of small numbers of precursor B-acute lymphoblastic leukemia.
    Babusíková O, Zelezníková T, Mlcáková A, Kusenda J, Stevulová L.
    Neoplasma; 2005 Jan; 52(6):502-9. PubMed ID: 16284697
    [Abstract] [Full Text] [Related]

  • 18. Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group.
    Borowitz MJ, Pullen DJ, Winick N, Martin PL, Bowman WP, Camitta B.
    Cytometry B Clin Cytom; 2005 Nov; 68(1):18-24. PubMed ID: 16184615
    [Abstract] [Full Text] [Related]

  • 19. Flow cytometric analysis of BCL-2 can distinguish small numbers of acute lymphoblastic leukaemia cells from B-cell precursors.
    Hartung L, Bahler DW.
    Br J Haematol; 2004 Oct; 127(1):50-8. PubMed ID: 15384977
    [Abstract] [Full Text] [Related]

  • 20. Easy discrimination of hematogones from lymphoblasts in B-cell progenitor acute lymphoblastic leukemia patients using CD81/CD58 expression ratio.
    Nagant C, Casula D, Janssens A, Nguyen VTP, Cantinieaux B.
    Int J Lab Hematol; 2018 Dec; 40(6):734-739. PubMed ID: 30113764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.